Skip to content

The impact of forest therapy on male patients with chronic nonspecific back pain in a standard rehabilitation program

The impact of forest therapy on male patients with chronic nonspecific back pain in a standard rehabilitation program - WiWa²

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00033747
Enrollment
65
Registered
2024-03-21
Start date
2024-04-05
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M40-M54

Interventions

Group 1: Males with nonspecific chronical low back pain (ICD: M40-M54) Treatment as usual (TAU) with recreation outdoor (forest therapy) Group 2: Males with nonspecific chronical low back pain (ICD: M

Sponsors

Rehafachzentrum Bad Füssing - Passau
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 67 Years

Inclusion criteria

Inclusion criteria: Patients (males) - who suffer from diagnosed chronic nonspecific back pain (Chronic Nonspecific Low Back Pain) (ICD M40-M54), - who have sufficient physical fitness to take part in outdoor activities, - who have sufficient linguistic and cognitive skills to participate in the study, especially in the sense of the skills that understand the declaration of consent and adequately implement exercise instructions from medical and health science professionals and be able to answer questionnaires - and who have signed a written consent form.

Exclusion criteria

Exclusion criteria: - untreated or acute malignant diseases, - previous operations in the lumbar spine area, - Suspected acute disc herniation, - Contraindications to balneotherapy: manifest internal medical concomitant diseases, - unstable high blood pressure, - thrombosis, - endocrine diseases such as hyperthyroidism and - hyperparathyroidism, - other uncontrolled metabolic diseases such as diabetes mellitus, active infectious diseases, incontinence, - hernias, - history of cerebrovascular and neurological diseases, - chronic, inflammatory rheumatism, - pathological disorders of the immune system, - severe respiratory diseases requiring oxygen supplementation, - acute or untreated mental illnesses, - Heart failure kidney failure, - alcohol abuse (ICD F10.1), - drug abuse (ICD F11-F19), - Taking >5mg/d prednisone, colchicine, Imuran, Methodrexate, azathioprine, - Cyclophosphamide, cyclosporine or interferon preparations - or do not have sufficient knowledge of German (spoken and written/questionnaires).

Design outcomes

Primary

MeasureTime frame
Does the rehabilitation success in the intervention group (forest therapy) differ from that of the control group with regard to the primary target parameters (Oswestry Low Back Disability Index (ODI)) and mobility of the back (spine check) in patients with chronic Nonspecific back pain (Chronic Nonspecific Low Back Pain)? - Oswestry Low Back Disability Index (ODI) - Spine-Check

Secondary

MeasureTime frame
2) Does the rehabilitation success in the intervention group (forest therapy) differ from that of the control group in terms of functional performance (back check)? 3) Does the rehabilitation success in the intervention group (forest therapy) differ from that of the control group with regard to static balance (MFT-S3 check)? 4) Does the rehabilitation success in the intervention group (forest therapy) differ from that of the control group with regard to pain (visual analogue scale for pain at rest and movement, consumption of painkillers)? 5) Does the rehabilitation success in the intervention group (forest therapy) differ from that of the control group with regard to the disease and health-related questionnaires SF12, WHO5, PHQ-4, WAI, FABQ, EHIS-PAQ?

Countries

Germany

Contacts

Public ContactGabriele Eichner

Rehafachzentrum Bad Füssing - Passau

forschung.orthopaedie@drv-bayernsued.de0049 8531 959-535

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026